You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
|
|---|---|
| Published in |
Molecular Neurodegeneration, November 2021
|
| DOI | 10.1186/s13024-021-00496-7 |
| Pubmed ID | |
| Authors |
Hannah Walgrave, Lujia Zhou, Bart De Strooper, Evgenia Salta |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 5 | 33% |
| Belgium | 2 | 13% |
| United States | 1 | 7% |
| United Kingdom | 1 | 7% |
| Unknown | 6 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 67% |
| Scientists | 4 | 27% |
| Science communicators (journalists, bloggers, editors) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 109 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 15% |
| Student > Bachelor | 13 | 12% |
| Student > Ph. D. Student | 9 | 8% |
| Student > Master | 7 | 6% |
| Professor | 4 | 4% |
| Other | 17 | 16% |
| Unknown | 43 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 14 | 13% |
| Neuroscience | 14 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 6% |
| Agricultural and Biological Sciences | 5 | 5% |
| Medicine and Dentistry | 4 | 4% |
| Other | 15 | 14% |
| Unknown | 50 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 June 2023.
All research outputs
#2,184,159
of 25,837,817 outputs
Outputs from Molecular Neurodegeneration
#255
of 990 outputs
Outputs of similar age
#49,349
of 446,323 outputs
Outputs of similar age from Molecular Neurodegeneration
#6
of 19 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 990 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.7. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,323 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.